HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,905,500 | -11.2% | 1,850,000 | 0.0% | 0.27% | -14.9% |
| Q2 2023 | $2,146,000 | +158.4% | 1,850,000 | +236.4% | 0.32% | +154.8% |
| Q1 2023 | $830,500 | -91.2% | 550,000 | -85.4% | 0.12% | -90.9% |
| Q4 2022 | $9,389,835 | -67.5% | 3,755,934 | -45.1% | 1.36% | -61.5% |
| Q3 2022 | $28,865,000 | +178.1% | 6,840,000 | +83.9% | 3.54% | +124.8% |
| Q2 2022 | $10,379,000 | -51.2% | 3,720,000 | 0.0% | 1.58% | -63.0% |
| Q1 2022 | $21,278,000 | -70.1% | 3,720,000 | -52.2% | 4.26% | -70.2% |
| Q4 2021 | $71,058,000 | -15.9% | 7,782,928 | -1.6% | 14.29% | -18.6% |
| Q3 2021 | $84,527,000 | -31.1% | 7,907,087 | 0.0% | 17.55% | -28.2% |
| Q2 2021 | $122,718,000 | +185.8% | 7,907,087 | +172.9% | 24.43% | +214.5% |
| Q3 2020 | $42,932,000 | +0.7% | 2,896,904 | 0.0% | 7.77% | +87.5% |
| Q2 2020 | $42,613,000 | +25.3% | 2,896,904 | 0.0% | 4.14% | -13.3% |
| Q1 2020 | $34,010,000 | -71.2% | 2,896,904 | -42.3% | 4.78% | -66.1% |
| Q4 2019 | $117,904,000 | +15.6% | 5,017,203 | -9.0% | 14.09% | -19.3% |
| Q3 2019 | $102,011,000 | -4.5% | 5,514,096 | -4.0% | 17.45% | +20.9% |
| Q2 2019 | $106,783,000 | -23.9% | 5,744,096 | 0.0% | 14.43% | -44.2% |
| Q1 2019 | $140,386,000 | -7.0% | 5,744,096 | -1.3% | 25.87% | -25.3% |
| Q4 2018 | $150,933,000 | -19.9% | 5,818,541 | -2.2% | 34.63% | +12.6% |
| Q3 2018 | $188,343,000 | -43.9% | 5,950,826 | -31.2% | 30.75% | -27.8% |
| Q2 2018 | $335,952,000 | +40.7% | 8,647,398 | -0.0% | 42.58% | +21.4% |
| Q1 2018 | $238,692,000 | +55.8% | 8,648,252 | +2.1% | 35.08% | +44.5% |
| Q4 2017 | $153,242,000 | +9.8% | 8,466,377 | -2.1% | 24.28% | -43.0% |
| Q3 2017 | $139,596,000 | +16.6% | 8,643,739 | 0.0% | 42.62% | +0.3% |
| Q2 2017 | $119,716,000 | -7.8% | 8,643,739 | -0.1% | 42.49% | -9.4% |
| Q1 2017 | $129,824,000 | +59.9% | 8,654,914 | +39.7% | 46.92% | +8.4% |
| Q4 2016 | $81,183,000 | -24.0% | 6,197,198 | 0.0% | 43.30% | -2.2% |
| Q3 2016 | $106,778,000 | -4.5% | 6,197,198 | 0.0% | 44.29% | -11.1% |
| Q2 2016 | $111,860,000 | +13.5% | 6,197,198 | +19.4% | 49.84% | +11.0% |
| Q1 2016 | $98,574,000 | -28.9% | 5,190,837 | 0.0% | 44.89% | -18.4% |
| Q4 2015 | $138,595,000 | +9.4% | 5,190,837 | 0.0% | 54.99% | +17.7% |
| Q3 2015 | $126,657,000 | -21.7% | 5,190,837 | 0.0% | 46.70% | -4.8% |
| Q2 2015 | $161,746,000 | +126.0% | 5,190,837 | +5.5% | 49.08% | +28.9% |
| Q1 2015 | $71,580,000 | +44.6% | 4,919,625 | 0.0% | 38.07% | +40.3% |
| Q4 2014 | $49,491,000 | +20.8% | 4,919,625 | 0.0% | 27.14% | +27.8% |
| Q3 2014 | $40,980,000 | -32.4% | 4,919,625 | 0.0% | 21.23% | -24.4% |
| Q2 2014 | $60,610,000 | -1.2% | 4,919,625 | +11.6% | 28.07% | -5.6% |
| Q1 2014 | $61,329,000 | – | 4,408,987 | – | 29.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |